Management of spinal cord injury patients with neurogenic lower urinary tract dysfunction using minimally invasive and surgical therapies in Taiwan

Groen J, Pannek J, Castro Diaz D, Del Popolo G, Gross T, Hamid R, Karsenty G, Kessler TM, Schneider M, 't Hoen L, Blok B (2016) Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology. Eur Urol 69:324-333

Chen YJ, Lo SH, Meng E, Shen JD, Eric Chou CL, Chen SF, Lee MH, Hsu CY, Ong HL, Chen JT, Chen SL, Tsai YA, Lin CC, Wu SY, Chiu B, Kuo HC, Taiwan Continence Society Spinal Cord Injury Study Group (2023) Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury–Part 1: Pathophysiology, treatment strategy and priority. Urol Sci 34:3–9

Google Scholar 

Chen SF, Kuo HC (2022) Interventional management and surgery of neurogenic lower urinary tract dysfunction in patients with chronic spinal cord injury: a urologist’s perspective. Low Urin Tract Symp 14:132–139

Article  Google Scholar 

Chang TL, Kuo HC (2023) The videourodynamic characteristics of patients with chronic spinal cord injury with different injury levels and bladder conditions. Urol Sci 34:46–52

Google Scholar 

Ong HL, Chiang IN, Hsu LN, Chin CW, Shao IH, Jang MY, Juan YS, Wang CC, Kuo HC, Taiwan Continence Society Spinal Cord Injury Study Group (2023) Conservative bladder management and medical treatment in chronic spinal cord injury patients. J Clin Med 12:2021

Article  PubMed  PubMed Central  Google Scholar 

Wu SY, Jhang JF, Liu HH, Chen JT, Li JR, Chiu B, Chen SL, Kuo HC (2023) Long-term surveillance and management of urological complications in chronic spinal cord-injured patients. J Clin Med 11:7307

Article  Google Scholar 

Lin YH, Fan YH, Wu CT, Shen YC, Hu JC, Huang SW, Chow PM, Chang PC, Liao CH, Chen YC, Victor C. Lin, Hsu CC, Chang SJ, Wang CC, Lin WY, Lin CC, Jiang YH, Kuo HC, Taiwan Continence Society Spinal Cord Injury Study Group (2023) Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury – Part 3: Surgical treatment in chronic spinal cord injured patients. Urol Sci 34:109-116

McGuire EJ, Cespedes RD, O’Connell HE (1996) Leak-point pressures. Urol Clin North Am 23:253–262

Article  CAS  PubMed  Google Scholar 

Stöhrer M, Goepel M, Kondo A, Kramer G, Madersbacher H, Millard R, Rossier A, Wyndaele JJ (1999) The standardization of terminology in neurogenic lower urinary tract dysfunction: with suggestions for diagnostic procedures. International Continence Society Standardization Committee. Neurourol Urodyn 18:139–158

Article  PubMed  Google Scholar 

Madersbacher S, Pycha A, Klingler CH, Mian C, Djavan B, Stulnig T, Marberger M (1999) Interrelationships of bladder compliance with age, detrusor instability, and obstruction in elderly men with lower urinary tract symptoms. Neurourol Urodyn 18:3–15

Article  CAS  PubMed  Google Scholar 

Weld KJ, Wall BM, Mangold TA, Steere EL, Dmochowski RR (2000) Influences on renal function in chronic spinal cord injured patients. J Urol 164:1490–1493

Article  CAS  PubMed  Google Scholar 

Mitsui T, Minami K, Furuno T, Morita H, Koyanagi T (2000) Is suprapubic cystostomy an optimal urinary management in high quadriplegics?. A comparative study of suprapubic cystostomy and clean intermittent catheterization. Eur Urol 38:434–438

Article  CAS  PubMed  Google Scholar 

Weld KJ, Dmochowski RR (2000) Effect of bladder management on urological complications in spinal cord injured patients. J Urol 163:768–772

Article  CAS  PubMed  Google Scholar 

Cameron AP, Wallner LP, Tate DG, Sarma AV, Rodriguez GM, Clemens JQ (2010) Bladder management after spinal cord injury in the United States 1972 to 2005. J Urol 184:213–217

Article  PubMed  Google Scholar 

Chen SF, Jiang YH, Jhang JF, Lee CL, Kuo HC (2014) Bladder management and urological complications in patients with chronic SCI in Taiwan. Tzu Chi Med J 26:25–28

Article  Google Scholar 

Ginsberg DA, Boone TB, Cameron AP, Gousse A, Kaufman MR, Keays E, Kennelly MJ, Lemack GE, Rovner ES, Souter LH, Yang CC, Kraus SR (2021) The AUA/SUFU guideline on adult neurogenic lower urinary tract dysfunction: treatment and follow-up. J Urol 206:1106–1113

Article  PubMed  Google Scholar 

Zhang D, Sun F, Yao H, Bao X, Wang D, Cui Y, Wu J (2021) The efficacy and safety of mirabegron for the treatment of neurogenic lower urinary tract dysfunction: a systematic review and meta-analysis. Front Pharmacol 12:756582

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reitz A, Haferkamp A, Kyburz T, Knapp PA, Wefer B, Schurch B (2004) The effect of tamsulosin on the resting tone and the contractile behaviour of the female urethra: a functional urodynamic study in healthy women. Eur Urol 46:235–240

Article  CAS  PubMed  Google Scholar 

Diokno AC, Koppenhoefer R (1976) Bethanechol chloride in neurogenic bladder dysfunction. Urology 8:455–458

Article  CAS  PubMed  Google Scholar 

Light JK, Scott FB (1982) Bethanechol chloride and the traumatic cord bladder. J Urol 128:85–87

Article  CAS  PubMed  Google Scholar 

Mangera A, Apostolidis A, Andersson KE, Dasgupta P, Giannantoni A, Roehrborn C, Novara G, Chapple C (2014) An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract disorders. Eur Urol 65:981–990

Article  CAS  PubMed  Google Scholar 

Dykstra DD, Sidi AA (1990) Treatment of detrusor-sphincter dyssynergia with botulinum a toxin: a double-blind study. Arch Phys Med Rehabil 71:24–26

CAS  PubMed  Google Scholar 

Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB (1996) Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 2:519–533

Google Scholar 

Kuo HC (2003) Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. J Urol 170:1908–1912

Article  CAS  PubMed  Google Scholar 

Kuo HC, Liu HT, Chuang YC, Birder LA, Chancellor MB (2014) Pilot study of liposome-encapsulated onabotulinumtoxina for patients with overactive bladder: a single-center study. Eur Urol 65:1117–1124

Article  CAS  PubMed  Google Scholar 

Chen SF, Kuo HC (2021) Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury? Tzu Chi Med J 33:101–107

Article  PubMed  Google Scholar 

Schurch B, de Sèze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, Plante P, Perrouin-Verbe B, Kumar C, Fraczek S, Brin MF, Botox Detrusor Hyperreflexia Study Team (2005) Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174:196–200

Article  CAS  PubMed  Google Scholar 

Kuo HC, Liu SH (2011) Effect of repeated detrusor onabotulinumtoxinA injections on bladder and renal function in patients with chronic spinal cord injuries. Neurourol Urodyn 30:1541–1545

Article  PubMed  Google Scholar 

Chen YC, Kuo HC (2014) The therapeutic effects of repeated detrusor injections between 200 or 300 units of onabotulinumtoxinA in chronic spinal cord injured patients. Neurourol Urodyn 33:129–134

Article  CAS  PubMed  Google Scholar 

Chen CY, Liao CH, Kuo HC (2011) Therapeutic effects of detrusor botulinum toxin a injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia. Spinal Cord 49:659–664

Article  PubMed  Google Scholar 

Kuo HC (2006) Therapeutic effects of suburothelial injection of botulinum a toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions. Urology 67:232–236

Article  PubMed  Google Scholar 

Grosse J, Kramer G, Stöhrer M (2005) Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 47:653–659

Article  CAS  PubMed  Google Scholar 

Kuo HC (2008) Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection. Urology 72:1056–1060

Article  PubMed  Google Scholar 

Chen SF, Kuo HC (2015) Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity. J Formos Med Assoc 114:583–589

Article  CAS  PubMed  Google Scholar 

Ginsberg DA, Drake MJ, Kaufmann A, Radomski S, Gousse AE, Chermansky CJ, Magyar A, Nicandro JP, Nitti VW, 191622-096 Investigators (2017) Long-term treatment with onabotulinumtoxinA results in consistent, durable improvements in health related quality of life in patients with overactive bladder. J Urol 198:897–904

Article  CAS  PubMed  Google Scholar 

Chen PY, Cheng JH, Wu ZS, Chuang YC (2022) New Frontiers of extracorporeal shock wave medicine in urology from bench to clinical studies. Biomedicines 10:675

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smith CP, Nishiguchi J, O’Leary M, Yoshimura N, Chancellor MB (2005) Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 65:37–41

Article  PubMed  Google Scholar 

Phelan MW, Franks M, Somogyi GT, Yokoyama T, Fraser MO, Lavelle JP, Yoshimura N, Chancellor MB (2001) Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 165:1107–1110

Article  CAS  PubMed  Google Scholar 

Kuo HC (2013) Therapeutic outcome and quality of life between urethral and detrusor botulinum toxin treatment for patients with spinal cord lesions and detrusor sphincter dyssynergia. Int J Clin Pract 67:1044–1049

Article  CAS  PubMed 

留言 (0)

沒有登入
gif